本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CALCIMEDICA

1.50
-0.0250-1.64%
盘后1.500.00000.00%18:27 EDT
成交量:2.04万
成交额:3.08万
市值:2,022.29万
市盈率:-1.23
高:1.53
开:1.49
低:1.48
收:1.53
数据加载中...

公司资料

公司名字:
CALCIMEDICA
交易所:
NASDAQ
成立时间:
- -
员工人数:
14
公司地址:
505 Coast Boulevard South,Suite 307,La Jolla,California,United States
邮编:
92037
电话:
传真:
- -
简介:
CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。公司候选产品作用于钙释放活化钙(“CRAC”)通道,将构成一类新药。

董事

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Eric W. Roberts
Chief Business Officer and Director,vice chairman
Robert N. Wilson
Director,Chair
Allan Shaw
Director
Eric Bjerkholt
Director
Fred Middleton
Director
Frederic Guerard
Director

股东

名称
职位
A. Rachel Leheny
Chief Executive Officer and Director
Michael J. Dunn
President and Chief Operating Officer
Daniel Geffken
Interim Chief Financial Officer
Eric W. Roberts
Chief Business Officer and Director,vice chairman
Kenneth A. Stauderman
Chief Scientific Officer
Sudarshan Hebbar
Chief Medical Officer